Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 3 trial evaluating adjuvant curcumin to improve recurrence-free survival after radical prostatectomy in prostate c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: yair lotan | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING